Chemical Structure (Exemestane 01)
Exemestane Tablet, Film Coated
Product Images NDC 51991-005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 51991-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Exemestane 02)
This is a statistical report on the disease-free survival of patients treated with either Exemestane or Tamoxifen. The report includes the proportion surviving, hazard ratio (HR), and p-value obtained from log-rank analysis. It also shows the number of patients randomized for each treatment and the duration of disease-free survival in months. The text also contains some unidentifiable characters, but they do not affect the overall understanding of the report.*
Figure 2 (Exemestane 03)
Not available.*
Principal Display Panel (25 mg Tablet Bottle Label)
This appears to be a product label for Exemestane Tablets containing 25mg. It includes a National Drug Code (NDC) number and a GTIN code. The lot number is also provided, with an associated expiration date. It mentions that the information will be coded in 2D during packing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
